Return to content in this issue

 

Generalized Eczema as a Transient Paradoxical Adverse Effect of Dupilumab

Betancor D1, Valverde-Monge M1, Díaz-Recuero JL2, Jo-Velasco ME3, Del Pozo V4,5, Sastre J1,5

1Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
2Dermatology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
3Pathology Department, Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain
4Department of Immunology, IIS-Fundación Jiménez Díaz, Madrid, Spain
5Centro de Investigación Biomedica En Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain

J Investig Allergol Clin Immunol 2025; Vol. 35(3)
doi: 10.18176/jiaci.1051

Key words: Dupilumab, Eczema, Cutaneous adverse reactions